VYRSA™ Technologies
Moving the Sacroiliac Joint Fusion Space Forward.
Moving the Sacroiliac Joint Fusion Space Forward.
VYRSA™ Technologies is an innovative spine and medical technology company, founded in 2021, dedicated to creating surgeon-designed solutions for MIS sacroiliac joint fusion for the treatment of sacroiliac joint dysfunction. The company is moving the Sacroiliac Joint Fusion Space Forward, with a commitment to revolutionizing the industry. Based in the United States, VYRSA™ Technologies operates within the manufacturing sector.
Despite being a newly established venture, VYRSA™ Technologies has not disclosed its last investment round or the involved investors. The absence of recent investment information suggests potential opportunities for venture capitalists interested in emerging technologies within the medical and spine industry. As a company focusing on innovation and addressing a specific medical need, VYRSA™ Technologies presents an intriguing prospect for investors seeking exposure to groundbreaking medical technologies.
With its focus on enhancing treatment options for sacroiliac joint dysfunction and its positioning in the manufacturing sector, VYRSA™ Technologies is poised for potential growth and impact within the healthcare industry.
There is no investment information
No recent news or press coverage available for VYRSA™ Technologies.
We care about your data, and we'd love to use cookies make your experience better.
